Literature DB >> 30833302

Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure.

Sara N Davison1.   

Abstract

Pain is common and poorly managed in patients with advanced CKD, likely due to both under and over prescription of appropriate analgesics. Poorly managed pain contributes to patients' poor quality of life and excessive health care use. There is tremendous variability within and between countries in prescribing patterns of analgesics, suggesting that factors other than patient characteristics account for these differences. This article discusses the pharmacologic management of acute and chronic pain in patients with advanced CKD, and the role analgesics, including opioids, play in the overall approach to pain management.
Copyright © 2019 by the American Society of Nephrology.

Entities:  

Keywords:  Analgesics, Opioid; Chronic Pain; NSAIDs; Pain Management; Pharmacology, Clinical; Prescriptions; Renal Insufficiency, Chronic; analgesics; chronic kidney disease; opioids; pain; quality of life

Year:  2019        PMID: 30833302      PMCID: PMC6556722          DOI: 10.2215/CJN.05180418

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  54 in total

Review 1.  Pharmacokinetics of the combination tablet of buprenorphine and naloxone.

Authors:  C Nora Chiang; Richard L Hawks
Journal:  Drug Alcohol Depend       Date:  2003-05-21       Impact factor: 4.492

2.  Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

Authors:  Edward J Randinitis; Edward L Posvar; Christine W Alvey; Allen J Sedman; Jack A Cook; Howard N Bockbrader
Journal:  J Clin Pharmacol       Date:  2003-03       Impact factor: 3.126

3.  Methadone is poorly removed by haemodialysis.

Authors:  V Furlan; A Hafi; M C Dessalles; J Bouchez; B Charpentier; A M Taburet
Journal:  Nephrol Dial Transplant       Date:  1999-01       Impact factor: 5.992

4.  Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine.

Authors:  Jörg Filitz; Norbert Griessinger; Reinhard Sittl; Rudi Likar; Jürgen Schüttler; Wolfgang Koppert
Journal:  Eur J Pain       Date:  2006-01-19       Impact factor: 3.931

5.  Measurements of plasma oxycodone, noroxycodone and oxymorphone levels in a patient with bilateral nephrectomy who is undergoing haemodialysis.

Authors:  M A Lee; M E F Leng; R M Cooper
Journal:  Palliat Med       Date:  2005-04       Impact factor: 4.762

6.  Pharmacokinetic and pharmacodynamic characterization of OROS and immediate-release amitriptyline.

Authors:  S K Gupta; J C Shah; S S Hwang
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

7.  Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.

Authors:  Columba Quigley; Simon Joel; Naina Patel; Amina Baksh; Maurice Slevin
Journal:  Palliat Med       Date:  2003-03       Impact factor: 4.762

8.  Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients.

Authors:  Sara N Davison; Gian S Jhangri; Jeffrey A Johnson
Journal:  Nephrol Dial Transplant       Date:  2006-09-06       Impact factor: 5.992

9.  The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients.

Authors:  Sara N Davison; Gian S Jhangri
Journal:  J Pain Symptom Manage       Date:  2005-11       Impact factor: 3.612

10.  Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.

Authors:  R B Raffa; E Friderichs; W Reimann; R P Shank; E E Codd; J L Vaught
Journal:  J Pharmacol Exp Ther       Date:  1992-01       Impact factor: 4.030

View more
  27 in total

1.  Pain Management in a Patient with Kidney Failure.

Authors:  Louise Moist
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-10       Impact factor: 8.237

2.  Safe and Effective Management of Pain in People with CKD.

Authors:  Sara N Davison; Sarah Rathwell
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-11       Impact factor: 8.237

Review 3.  Methadone for Pain Management: A Pharmacotherapeutic Review.

Authors:  Denise Kreutzwiser; Qutaiba A Tawfic
Journal:  CNS Drugs       Date:  2020-08       Impact factor: 5.749

Review 4.  Methadone: applications in pediatric anesthesiology and critical care medicine.

Authors:  Joseph D Tobias
Journal:  J Anesth       Date:  2021-01-12       Impact factor: 2.078

Review 5.  Perioperative Pain Management and Opioid Stewardship: A Practical Guide.

Authors:  Sara J Hyland; Kara K Brockhaus; William R Vincent; Nicole Z Spence; Michelle M Lucki; Michael J Howkins; Robert K Cleary
Journal:  Healthcare (Basel)       Date:  2021-03-16

6.  Associations of Opioid Prescriptions with Death and Hospitalization across the Spectrum of Estimated GFR.

Authors:  Tessa K Novick; Aditya Surapaneni; Jung-Im Shin; G Caleb Alexander; Lesley A Inker; Eric A Wright; Alex R Chang; Morgan E Grams
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-03       Impact factor: 8.237

7.  Use of Potentially Nephrotoxic Medications by U.S. Adults with Chronic Kidney Disease: NHANES, 2011-2016.

Authors:  Shaheen Kurani; Molly Moore Jeffery; Bjorg Thorsteinsdottir; LaTonya J Hickson; Erin F Barreto; Jordan Haag; Rachel Giblon; Nilay D Shah; Rozalina G McCoy
Journal:  J Gen Intern Med       Date:  2019-12-02       Impact factor: 5.128

8.  Mortality Risk in Chronic Kidney Disease Patients Transitioning to Dialysis: Impact of Opiate and Non-Opiate Use.

Authors:  Amy S You; Kamyar Kalantar-Zadeh; Elani Streja; Christina Park; John J Sim; Ekamol Tantisattamo; Jui-Ting Hsiung; Yoshitsugu Obi; Praveen K Potukuchi; Alpesh N Amin; Danh V Nguyen; Csaba P Kovesdy; Connie M Rhee
Journal:  Am J Nephrol       Date:  2020-08-10       Impact factor: 3.754

Review 9.  Opioids in Hemodialysis Patients.

Authors:  Sahir Kalim; Karen S Lyons; Sagar U Nigwekar
Journal:  Semin Nephrol       Date:  2021-01       Impact factor: 5.299

Review 10.  Substance use among adolescents and young adults with chronic kidney disease or kidney failure.

Authors:  Nianzhou Xiao; Hua Chai; Abiodun Omoloja
Journal:  Pediatr Nephrol       Date:  2021-03-09       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.